Cargando…

Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice

Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfuhlmann, Katrin, Pfluger, Paul T., Schriever, Sonja C., Müller, Timo D., Tschöp, Matthias H., Stemmer, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584967/
https://www.ncbi.nlm.nih.gov/pubmed/28873424
http://dx.doi.org/10.1371/journal.pone.0183488
_version_ 1783261537340751872
author Pfuhlmann, Katrin
Pfluger, Paul T.
Schriever, Sonja C.
Müller, Timo D.
Tschöp, Matthias H.
Stemmer, Kerstin
author_facet Pfuhlmann, Katrin
Pfluger, Paul T.
Schriever, Sonja C.
Müller, Timo D.
Tschöp, Matthias H.
Stemmer, Kerstin
author_sort Pfuhlmann, Katrin
collection PubMed
description Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in selected brain areas or white adipose tissue. Hypothalamic Dusp6 mRNA levels remained unchanged in chow-fed lean vs. high fat diet (HFD) fed obese C57Bl/6J mice, and in C57Bl/6J mice undergoing prolonged fasting or refeeding with fat free diet (FFD) or HFD. Similarly, Dusp6 expression levels were unchanged in selected brain regions of Lep(ob) mice treated with 1 mg/kg of leptin for 6 days, compared to pair-fed or saline-treated Lep(ob) controls. Dusp6 expression levels remained unaltered in vitro in primary adipocytes undergoing differentiation, but were increased in eWAT of HFD-fed obese C57Bl/6J mice, compared to chow-fed lean controls. Global chow-fed DUSP6 KO mice displayed reduced body weight and lean mass and slightly increased fat mass at a young age, which is indicative for early-age weight retardation. Subsequent exposure to HFD led to a significant increase in lean mass and body weight in DUSP6 deficient mice, compared to WT controls. Nevertheless, after 26 weeks of high-fat diet exposure, we observed comparable body weight, fat and lean mass in DUSP6 WT and KO mice, suggesting overall normal susceptibility to develop obesity. In line with the increased weight gain to compensate for early-age weight retardation, HFD-fed DUSP6 KO displayed increased expression levels of anabolic genes involved in lipid and cholesterol metabolism in the epididymal white adipose tissue (eWAT), compared to WT controls. Glucose tolerance was perturbed in both chow-fed lean or HFD-fed obese DUSP6 KO, compared to their respective WT controls. Overall, our data indicate that DUSP6 deficiency has limited impact on the regulation of energy metabolism, but impairs systemic glucose tolerance. Our data are in conflict to earlier reports that propose protection from diet-induced obesity and glucose intolerance in DUSP6 deficient mice. Reasons for the discrepancies remain elusive, but may entail differential genetic backgrounds, environmental factors such as the type and source of HFD, or alterations in the gut microbiome between facilities.
format Online
Article
Text
id pubmed-5584967
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55849672017-09-15 Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice Pfuhlmann, Katrin Pfluger, Paul T. Schriever, Sonja C. Müller, Timo D. Tschöp, Matthias H. Stemmer, Kerstin PLoS One Research Article Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in selected brain areas or white adipose tissue. Hypothalamic Dusp6 mRNA levels remained unchanged in chow-fed lean vs. high fat diet (HFD) fed obese C57Bl/6J mice, and in C57Bl/6J mice undergoing prolonged fasting or refeeding with fat free diet (FFD) or HFD. Similarly, Dusp6 expression levels were unchanged in selected brain regions of Lep(ob) mice treated with 1 mg/kg of leptin for 6 days, compared to pair-fed or saline-treated Lep(ob) controls. Dusp6 expression levels remained unaltered in vitro in primary adipocytes undergoing differentiation, but were increased in eWAT of HFD-fed obese C57Bl/6J mice, compared to chow-fed lean controls. Global chow-fed DUSP6 KO mice displayed reduced body weight and lean mass and slightly increased fat mass at a young age, which is indicative for early-age weight retardation. Subsequent exposure to HFD led to a significant increase in lean mass and body weight in DUSP6 deficient mice, compared to WT controls. Nevertheless, after 26 weeks of high-fat diet exposure, we observed comparable body weight, fat and lean mass in DUSP6 WT and KO mice, suggesting overall normal susceptibility to develop obesity. In line with the increased weight gain to compensate for early-age weight retardation, HFD-fed DUSP6 KO displayed increased expression levels of anabolic genes involved in lipid and cholesterol metabolism in the epididymal white adipose tissue (eWAT), compared to WT controls. Glucose tolerance was perturbed in both chow-fed lean or HFD-fed obese DUSP6 KO, compared to their respective WT controls. Overall, our data indicate that DUSP6 deficiency has limited impact on the regulation of energy metabolism, but impairs systemic glucose tolerance. Our data are in conflict to earlier reports that propose protection from diet-induced obesity and glucose intolerance in DUSP6 deficient mice. Reasons for the discrepancies remain elusive, but may entail differential genetic backgrounds, environmental factors such as the type and source of HFD, or alterations in the gut microbiome between facilities. Public Library of Science 2017-09-05 /pmc/articles/PMC5584967/ /pubmed/28873424 http://dx.doi.org/10.1371/journal.pone.0183488 Text en © 2017 Pfuhlmann et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pfuhlmann, Katrin
Pfluger, Paul T.
Schriever, Sonja C.
Müller, Timo D.
Tschöp, Matthias H.
Stemmer, Kerstin
Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
title Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
title_full Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
title_fullStr Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
title_full_unstemmed Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
title_short Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
title_sort dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584967/
https://www.ncbi.nlm.nih.gov/pubmed/28873424
http://dx.doi.org/10.1371/journal.pone.0183488
work_keys_str_mv AT pfuhlmannkatrin dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice
AT pflugerpault dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice
AT schrieversonjac dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice
AT mullertimod dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice
AT tschopmatthiash dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice
AT stemmerkerstin dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice